Literature DB >> 7895554

Serological parameters in assessment of degree of gastritis in healthy volunteers.

J Kreuning1, J Lindeman, I Biemond, C B Lamers.   

Abstract

This study was undertaken in healthy volunteers to determine the relation between serum levels of pepsinogen A, pepsinogen C, pepsinogen A:C ratio, and gastrin on the one hand and histology of the gastric mucosa on the other. The grade of gastritis was scored separately for antral and fundic mucosa by three different classifications: Whitehead, activity, and the Sydney score. Among 48 healthy volunteers studied, 17 were found to have gastritis according to the criteria of Whitehead. Fourteen of these 17 subjects with gastritis had H. pylori in gastric biopsies. In all 48 subjects serum pepsinogen A (r = 0.298-0.506; P < 0.01-P < 0.05), pepsinogen A:C ratio (r between -0.377 and -0.495; P < 0.001-P < 0.05) and gastrin (r = 0.38-0.695; P = 0.007-P < 0.01) were significantly correlated to the severity of both antral and body gastritis as assessed by all three classifications. In contrast, there was no significant correlation between serum pepsinogen C and any of the gastritis scores. When the 17 subjects with gastritis were analyzed separately, there were no correlations between the parameters studied and gastritis of the antrum. Regarding the corpus mucosa, serum PgA correlated significantly with the activity score (r = 0.520; P = 0.03), weakly with the Sydney score (r = 0.465; P = 0.06), but not with the Whitehead score. Serum PgC correlated with the Whitehead (r = 0.555; P = 0.02) and Sydney score (r = 0.523; P = 0.03), but only weakly with the activity score (r = 0.441; P = 0.08).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7895554     DOI: 10.1007/bf02064379

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

Review 1.  The Sydney System: histological division.

Authors:  A B Price
Journal:  J Gastroenterol Hepatol       Date:  1991 May-Jun       Impact factor: 4.029

2.  Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum.

Authors:  I M Samloff
Journal:  Gastroenterology       Date:  1982-01       Impact factor: 22.682

3.  Serum pepsinogen I and gastrin concentrations in children positive for Helicobacter pylori.

Authors:  G Oderda; D Vaira; D Dell'Olio; J Holton; M Forni; F Altare; N Ansaldi
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

4.  Radioimmunoassay of human pepsinogen A and pepsinogen C.

Authors:  I Biemond; J B Jansen; L F Crobach; J Kreuning; C B Lamers
Journal:  J Clin Chem Clin Biochem       Date:  1989-01

5.  Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients.

Authors:  G Biasco; G M Paganelli; D Vaira; J Holton; G Di Febo; S Brillanti; M Miglioli; L Barbara; I M Samloff
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

6.  Serum gastrin in chronic gastritis.

Authors:  M G Korman; R G Strickland; J Hansky
Journal:  Br Med J       Date:  1971-04-03

7.  Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis.

Authors:  M Kekki; I M Samloff; K Varis; T Ihamäki
Journal:  Scand J Gastroenterol Suppl       Date:  1991

8.  Helicobacter pylori in dyspeptic patients: quantitative association with severity of gastritis, intragastric pH, and serum gastrin concentration.

Authors:  T Karttunen; S Niemelä; J Lehtola
Journal:  Scand J Gastroenterol Suppl       Date:  1991

9.  Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer.

Authors:  K Varis; M Kekki; M Härkönen; P Sipponen; I M Samloff
Journal:  Scand J Gastroenterol Suppl       Date:  1991

10.  Serum gastrin and atrophic gastritis in achlorhydric patients with and without pernicious anemia.

Authors:  R Stockbrügger; L Angervall; G Lundqvist
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

View more
  4 in total

1.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

2.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

3.  Multifaceted Assessment of Chronic Gastritis: A Study of Correlations between Serological, Endoscopic, and Histological Diagnostics.

Authors:  Toshitatsu Takao; Takeshi Ishikawa; Takashi Ando; Madoka Takao; Tsuguhiro Matsumoto; Yutaka Isozaki; Mika Okita; Yasuyuki Nagao; Hirokazu Oyamada; Keiichi Yokoyama; Atsushi Tatebe; Kazuhiko Uchiyama; Osamu Handa; Tomohisa Takagi; Nobuaki Yagi; Satoshi Kokura; Yuji Naito; Toshikazu Yoshikawa
Journal:  Gastroenterol Res Pract       Date:  2011-07-10       Impact factor: 2.260

4.  Pepsinogen II can be a potential surrogate marker of morphological changes in corpus before and after H. pylori eradication.

Authors:  Sadegh Massarrat; Arghavan Haj-Sheykholeslami; Ashraf Mohamadkhani; Nasrin Zendehdel; Ali Aliasgari; Naser Rakhshani; Manfred Stolte; Seyed Mehdi Shahidi
Journal:  Biomed Res Int       Date:  2014-06-17       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.